Insights

Comprehensive Drug Development Penn Pharma offers end-to-end capabilities from molecule development to commercial manufacturing, enabling clients to streamline their drug supply chain and reduce time to market. This integrated service model presents opportunities for pharmaceutical companies seeking efficient, single-source manufacturing solutions.

Regulatory Expertise With licensed facilities by both MHRA and FDA, Penn Pharma has established a strong compliance track record, appealing to clients that prioritize high regulatory standards and global market access, particularly in Europe and the USA.

Capacity Expansion Recent investments in expanding manufacturing capacity, including a new containment facility and large-scale production suites, position Penn Pharma as a capable partner for high-volume drug manufacturing, especially for potent and complex molecules.

Specialized Service Offerings Penn Pharma's expertise in producing highly potent molecules, unlicensed medicines, and various dosage forms enables it to serve niche segments and specialty pharma clients with tailored manufacturing needs, creating market differentiation.

Relatively Small Revenue Scale Despite extensive experience and capacity, Penn Pharma operates with a revenue between 1 million and 10 million USD, indicating potential for expanding sales efforts to larger pharmaceutical companies or exploring higher-value markets to maximize growth opportunities.

Penn Pharma, a PCI company Tech Stack

Media & News

Penn Pharma, a PCI company's Email Address Formats

Penn Pharma, a PCI company uses at least 2 format(s):
Penn Pharma, a PCI company Email FormatsExamplePercentage
First.Last@pciservices.comJohn.Doe@pciservices.com
89%
Last@pciservices.comDoe@pciservices.com
7%
FLast@pciservices.comJDoe@pciservices.com
3%
First.MiddleLast@pciservices.comJohn.MichaelDoe@pciservices.com
1%
First.Last@pennpharm.co.ukJohn.Doe@pennpharm.co.uk
46%
FLast@pennpharm.co.ukJDoe@pennpharm.co.uk
4%
First.Last@pennpharm.co.ukJohn.Doe@pennpharm.co.uk
46%
FLast@pennpharm.co.ukJDoe@pennpharm.co.uk
4%

Frequently Asked Questions

What is Penn Pharma, a PCI company's phone number?

Minus sign iconPlus sign icon
You can contact Penn Pharma, a PCI company's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Penn Pharma, a PCI company's official website and social media links?

Minus sign iconPlus sign icon
Penn Pharma, a PCI company's official website is pennpharm.co.uk and has social profiles on LinkedInCrunchbase.

What is Penn Pharma, a PCI company's NAICS code?

Minus sign iconPlus sign icon
Penn Pharma, a PCI company's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Penn Pharma, a PCI company have currently?

Minus sign iconPlus sign icon
As of December 2025, Penn Pharma, a PCI company has approximately 1K employees across 2 continents, including EuropeAsia. Key team members include Director Of Quality Assurance (qp): K. S.Director Of Supply Chain: A. S.Director's Pa: C. E.. Explore Penn Pharma, a PCI company's employee directory with LeadIQ.

What industry does Penn Pharma, a PCI company belong to?

Minus sign iconPlus sign icon
Penn Pharma, a PCI company operates in the Pharmaceutical Manufacturing industry.

What is Penn Pharma, a PCI company's email format?

Minus sign iconPlus sign icon
Penn Pharma, a PCI company's email format typically follows the pattern of First.Last@pciservices.com. Find more Penn Pharma, a PCI company email formats with LeadIQ.

How much funding has Penn Pharma, a PCI company raised to date?

Minus sign iconPlus sign icon
As of December 2025, Penn Pharma, a PCI company has raised $66M in funding. The last funding round occurred on Apr 26, 2007 for $66M.

When was Penn Pharma, a PCI company founded?

Minus sign iconPlus sign icon
Penn Pharma, a PCI company was founded in 1979.

Penn Pharma, a PCI company

Pharmaceutical ManufacturingWales, United Kingdom1001-5000 Employees

Penn Pharma, a PCI company, has over 35 years of experience in providing integrated drug development, clinical trial supply, manufacturing and packaging services to the international healthcare industry. 

With a full range of contract services available Penn is able to take compounds from the earliest stages of development through to commercialisation. It is this “molecule to market” offering from Penn that ensures true speed to market for our global client base.

Recognised for our regulatory and export experience, Penn supplies many markets including Europe, the USA, South America and Japan. Our Knowledge and expertise, has enabled us to become the trusted partner for many of the world’s top pharmaceutical companies. 

In recent years, we have invested to expand our operations including a purpose-built contained manufacturing facility which opened in 2013 followed by a large-scale commercial manufacturing suite which became operational in 2014. With this significant expansion programme, we are now able to offer over 0.5 billion doses of capacity on site ranging from 1kg to 300kg scale for non-potent and 1kg to 120kg scale for potent molecules.

Penn's facilities meet the highest quality and regulatory standards, are licensed by the MHRA and inspected by the FDA.  Penn is also licensed by the UK Home Office for importation and storage of controlled drugs.

Core services include:
Formulation development, Analytical development & stability, Clinical trial supply, Manufacturing - Clinical/Commercial/Contained, including highly potent molecules, from pilot to commercial batch sizes, Manufacture of specials (unlicensed medicines), Supply chain management - including the storage, distribution, returns, destruction and inventory management of clinical trial material, QA services, Qualified Person (QP) Release.  
Dosage forms include; Solid - tablets, capsules, granules, powders, Semi solid - creams, ointment & gels, Liquids - solutions & suspensions.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1979
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $66M

    Penn Pharma, a PCI company has raised a total of $66M of funding over 1 rounds. Their latest funding round was raised on Apr 26, 2007 in the amount of $66M.

  • $1M$10M

    Penn Pharma, a PCI company's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $66M

    Penn Pharma, a PCI company has raised a total of $66M of funding over 1 rounds. Their latest funding round was raised on Apr 26, 2007 in the amount of $66M.

  • $1M$10M

    Penn Pharma, a PCI company's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.